Myeloma is called multiple because it frequently involves multiple areas in the body. The evolution of prognostic factors in multiple myeloma. Your doctor will consider a range of factors in determining your individual prognosis. High risk multiple myeloma is the last step in the progression of risk in multiple myeloma. Understanding and properly classifying myeloma is not easy, and requires information about the genetic makeup of the myeloma. The diagnosis and treatment of multiple myeloma ncbi. A prognosis is the doctors best estimate of how cancer will affect someone and how it will respond to treatment. Multiple myeloma mm is a heterogeneous hematologic malignancy involving the proliferation of plasma cells derived by different genetic events contributing to the. Presenting symptoms of multiple myeloma mm are vague and nonspecific. Multiple myeloma mm is a plasma cell dyscrasia characterized by terminally differentiated plasma cells, infiltration of the bone marrow by plasma cells, and the presence of a monoclonal. Treatment, prognosis, survival rate for stage3 myeloma. Signs and symptoms of multiple myeloma tests to find multiple myeloma stages and outlook prognosis after a cancer diagnosis, staging provides important information about the extent. Pdf the evolution of prognostic factors in multiple myeloma.
Myeloma is often called multiple myeloma because most people 90% have multiple bone lesions at the. Get an overview of multiple myeloma and the latest key statistics in the us. Multiple myeloma is a type of rare cancer that affects the plasma cells of the body. Multiple myeloma also known as myeloma is a blood cancer that develops in the plasma cells found in the soft, spongy tissue at the center of the bones, which is made in the bone marrow. Multiple myeloma mm is a heterogeneous hematologic malignancy involving the proliferation of plasma cells derived by different genetic events contributing to the development, progression. Learn how doctors decide the stage of your cancer, and what that means for your recovery. Median survival is about three years, but some patients have a life expectancy of 10 years.
Exposure to radiation, organic chemicals such as benzene, herbicides, and insecticides may play a role. Multiple myeloma is a systemic malignant disease of the blood, in most cases incurable. Multiple myeloma mm is a debilitating malignancy that is part of a spectrum of diseases ranging from monoclonal gammopathy of unknown significance mgus to plasma cell. The pres ence of renal diseaserenal insufficiency, in particularin pa tients with myeloma is of prognostic. Multiple myeloma accounts for approximately 10% of hematologic malignancies. Multiple myeloma symptoms, diagnosis and treatment bmj. Multiple myeloma, the most common bone malignancy, is occurring with increasing frequency in older persons. Overall, the prognosis, or predicted course of disease, for patients with multiple myeloma has improved greatly in the past decade due to continuing research. By the time myeloma reaches stage 3, the cancer is already considered to be at the last stage. When it comes to multiple myeloma sometimes referred to as.
Early detection poses a diagnostic challenge in primary care. Pdf multiple myeloma is characterised by the proliferation of malignant plasma cells within the bone marrow, which produce an abnormal. The most commonly used clinical staging system, the duriesalmon staging system, demonstrates. It is characterised by a clonal population of bone marrow plasma cells which. Multiple myeloma is characterized by the uncontrolled proliferation of monoclonal plasma cells in the bone marrow, leading to production of. When your doctor diagnoses multiple myeloma, she will also tell you the stage your disease is in. Sometimes, multiple myeloma is found early when a routine blood test shows an abnormally high amount of protein in the blood. Find out how multiple myeloma is tested for, diagnosed, and staged. It is not possible for any doctor to predict the exact course of the disease, but your medical team can predict how the myeloma. Multiple myeloma is a blood cancer that develops in the bone marrow figure 1. Multiple myeloma is seldom cured, although treatment can relieve symptoms, induce remission, and prolong life. Clinical features, laboratory manifestations, and diagnosis formulary drug information for this topic no drug references linked in this topic.
Prognosis is the word your healthcare team may use to describe your likely outcome from cancer and cancer. Myeloma is a type of cancer that develops from plasma cells in the bone marrow. Multiple myeloma is diagnosed based on the results of clinical tests. Staging and prognosis for myeloma cancer council nsw. The outlook for people with multiple myeloma varies by the stage extent of the cancer in general, the survival rates are higher for people with earlier stage cancers. Although multiple myeloma is rarely curable, it is a highly manageable disease. In particular, the median survival of patients with multiple myeloma has been markedly prolonged through the use of targeted drugs such as proteasome inhibitors and immune modulators. Usually, the bones of the hands, feet, and lower parts of the arms and legs are not affected, preserving the function of these critical areas. Learn about the risk factors for multiple myeloma and what you might be able to do to help lower your risk. In germany there are around 6500 new cases of multiple. Prognosis is a word that describes the likely forecast or course that a disease will take as it progresses. Different types of multiple myeloma the myeloma crowd. Often, multiple myeloma causes no symptoms until it reaches an advanced stage.
Patients may present with bone pain or with symptoms that are often nonspecific, such as. Multiple myeloma information and resources myeloma explained. Abstract multiple myeloma accounts for approximately 10% of. Higher risk myeloma multiple myeloma survival rate. Multiple myeloma prognosis clinical staging systems. A prognosis is the doctors best estimate of how cancer will. Multiple myeloma is a clonal plasma cell malignancy that accounts for slightly more than 10% of all hematologic cancers. Multiple myeloma prognosis multiple myeloma survival rate. Test findings such as cancer cells in the bone marrow, abnormal proteins in the blood, low levels of red blood cells, imaging scans that show tumors, and kidney dysfunction are evidence that doctors use to diagnose myeloma. Prognosis and survival for multiple myeloma canadian. Multiple myeloma comes in a variety of forms and is not a single disease. Genetic factors and viral infection may also influence the risk of developing multiple myeloma. Multiple myeloma early detection, diagnosis, and staging. Learn more about the symptoms, causes, diagnosis, risk factors, and treatment of multiple myeloma.
Multiple myeloma blood american society of hematology. Patients may present with nonspecific symptoms, such as nausea, vom iting, malaise, weakness, recurrent infections, or weight loss. Multiple myeloma is the second most common type of blood cancer after leukemia. Pdf multiple myeloma mm is a heterogeneous hematologic malignancy involving the proliferation of plasma cells derived by different. Multiple myeloma mm, also known as symptomatic plasma cell myeloma, is a plasma cell malignancy. The outlook for multiple myeloma depends on many different factors. High risk multiple myeloma represents about 15% of all myeloma cases, however it has historically. Multiple myeloma prognosis r iss revised international staging system for myeloma cllipi the international prognostic index for patients with chronic lymphocytic leukemia expected. Your chances for recovery prognosis what is a prognosis. When multiple myeloma is diagnosed, the stage of the disease varies from patient to patient. As active multiple myeloma gets worse, youll likely feel sicker, with fatigue or bone pain. If you have multiple myeloma, you may have questions about your prognosis.
110 183 1146 686 402 1187 1090 1061 452 808 1477 515 745 353 1100 589 521 1115 611 86 1120 1331 1384 140 189 1484 636 66 533 307 438 76